Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 6/2016

01-06-2016 | Original Article

Population-Based Epidemiology and Mortality of Small Malignant Gastrointestinal Stromal Tumors in the USA

Authors: Taylor M. Coe, Katherine E. Fero, Paul T. Fanta, Robert J. Mallory, Chih-Min Tang, James D. Murphy, Jason K. Sicklick

Published in: Journal of Gastrointestinal Surgery | Issue 6/2016

Login to get access

Abstract

Background and Aims

Gastrointestinal stromal tumors (GISTs) have significant variability in size and malignant behavior. Our current understanding is limited to pathological analyses, autopsy studies, and small case series. The aim of the current study is to define the risk factors, incidence, and mortality rates of GIST <2 cm in the National Cancer Institute’s Surveillance, Epidemiology, and End Results database.

Methods

Patients with histologically confirmed malignant GIST <2 cm were studied from 2001 to 2011. GIST was defined by GI tumor site codes and GIST-specific histology codes.

Results

We identified 378 patients with GIST <2 cm. The average age at diagnosis was 64.0 years with equal sex distribution. The most common tumor location was the stomach (62.2 %), followed by the small intestine (23.3 %), colon (5.6 %), and rectum (3.4 %). Most patients had localized disease (79.4 %), but 11.4 % had regional/distant metastatic disease. The annual incidence rate was 4.2 per 10,000,000 (10M). This was the highest among Blacks (7.6 per 10M). Among patients with GIST and no additional cancers, the 5-year GIST-specific mortality was 12.9 %. Moreover, there was a significantly increased 5-year GIST-specific mortality in those patients who had regionally advanced (34.0 %) or metastatic GIST (34.3 %), as compared to those patients with localized GIST (5.6 %).

Conclusions

This study represents the first population-based analysis of malignant GIST <2 cm. While quite rare, these tumors have an underappreciated disease-specific mortality. Further studies are needed to define the underlying reasons for the identified racial differences, to develop novel risk assessment schema for patients with these small tumors, and to determine appropriate indications for resection and/or medical therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–580.PubMedCrossRef Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–580.PubMedCrossRef
2.
go back to reference DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–58.PubMedPubMedCentralCrossRef DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–58.PubMedPubMedCentralCrossRef
3.
4.
go back to reference Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015;24(1):298–302.CrossRef Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015;24(1):298–302.CrossRef
5.
go back to reference Chetty R. Small and microscopically detected gastrointestinal stromal tumours: an overview. Pathology. 2008;40(1):9–12.PubMedCrossRef Chetty R. Small and microscopically detected gastrointestinal stromal tumours: an overview. Pathology. 2008;40(1):9–12.PubMedCrossRef
6.
go back to reference Dirnhofer S, Leyvraz S. Current standards and progress in understanding and treatment of GIST. Swiss Medical Weekly. 2009;139(7–8):90–102.PubMed Dirnhofer S, Leyvraz S. Current standards and progress in understanding and treatment of GIST. Swiss Medical Weekly. 2009;139(7–8):90–102.PubMed
7.
go back to reference Rammohan A, Sathyanesan J, Rajendran K, et al. A gist of gastrointestinal stromal tumors: a review. World Journal of Gastrointestinal Oncology. 2013;5(6):102–112.PubMedPubMedCentralCrossRef Rammohan A, Sathyanesan J, Rajendran K, et al. A gist of gastrointestinal stromal tumors: a review. World Journal of Gastrointestinal Oncology. 2013;5(6):102–112.PubMedPubMedCentralCrossRef
8.
go back to reference Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. Journal of the National Comprehensive Cancer Network: JNCCN. 2010;8 Suppl 2:S1-41; quiz S42-44.PubMedPubMedCentral Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. Journal of the National Comprehensive Cancer Network: JNCCN. 2010;8 Suppl 2:S1-41; quiz S42-44.PubMedPubMedCentral
10.
go back to reference Scherubl H, Faiss S, Knoefel WT, Wardelmann E. Management of early asymptomatic gastrointestinal stromal tumors of the stomach. World Journal of Gastrointestinal Endoscopy. 2014;6(7):266–271.PubMedPubMedCentralCrossRef Scherubl H, Faiss S, Knoefel WT, Wardelmann E. Management of early asymptomatic gastrointestinal stromal tumors of the stomach. World Journal of Gastrointestinal Endoscopy. 2014;6(7):266–271.PubMedPubMedCentralCrossRef
11.
go back to reference Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. “Seedling” mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. The American Journal of Surgical Pathology. 2007;31(11):1629–1635.PubMedCrossRef Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. “Seedling” mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. The American Journal of Surgical Pathology. 2007;31(11):1629–1635.PubMedCrossRef
12.
go back to reference Agaimy A, Wunsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. The American Journal of Surgical Pathology. 2007;31(1):113–120.PubMedCrossRef Agaimy A, Wunsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. The American Journal of Surgical Pathology. 2007;31(1):113–120.PubMedCrossRef
13.
go back to reference Kawanowa K, Sakuma Y, Sakurai S, et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol. 2006;37(12):1527–1535.PubMedCrossRef Kawanowa K, Sakuma Y, Sakurai S, et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol. 2006;37(12):1527–1535.PubMedCrossRef
14.
go back to reference Chan CHF, Cools-Lartigue J, Marcus VA, Feldman LS, Ferri LE. The impact of incidental gastrointestinal stromal tumours on patients undergoing resection of upper gastrointestinal neoplasms. Canadian Journal of Surgery. 2012;55(6):366–370.PubMedCentralCrossRef Chan CHF, Cools-Lartigue J, Marcus VA, Feldman LS, Ferri LE. The impact of incidental gastrointestinal stromal tumours on patients undergoing resection of upper gastrointestinal neoplasms. Canadian Journal of Surgery. 2012;55(6):366–370.PubMedCentralCrossRef
15.
go back to reference Rossi S, Gasparotto D, Toffolatti L, et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. The American Journal of Surgical Pathology. 2010;34(10):1480–1491.PubMedCrossRef Rossi S, Gasparotto D, Toffolatti L, et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. The American Journal of Surgical Pathology. 2010;34(10):1480–1491.PubMedCrossRef
16.
go back to reference Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005;100(1):162–168.PubMedCrossRef Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005;100(1):162–168.PubMedCrossRef
17.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: released April 2014 (updated 5/7/2014), based on the November 2013 submission. Surveillance, Epidemiology, and End Results (SEER) Program (www.​seer.​cancer.​gov) SEER*Stat Database: released April 2014 (updated 5/7/2014), based on the November 2013 submission.
18.
go back to reference Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. U.S. Bureau of the Census, Current Population Reports, P25-1130, U.S. Government Printing Office Washington, DC, 1996. Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. U.S. Bureau of the Census, Current Population Reports, P25-1130, U.S. Government Printing Office Washington, DC, 1996.
19.
go back to reference Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Statistical Methods in Medical Research. 2006;15(6):547–569.PubMedCrossRef Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Statistical Methods in Medical Research. 2006;15(6):547–569.PubMedCrossRef
20.
go back to reference Murphy JD, Ma GL, Baumgartner JM, et al. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: a population-based study. Cancer. 2015. Murphy JD, Ma GL, Baumgartner JM, et al. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: a population-based study. Cancer. 2015.
21.
go back to reference Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. The American Journal of Surgical Pathology. 2005;29(1):52–68.PubMedCrossRef Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. The American Journal of Surgical Pathology. 2005;29(1):52–68.PubMedCrossRef
22.
go back to reference Call J, Walentas CD, Eickhoff JC, Scherzer N. Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry. BMC Cancer. 2012;12:90.PubMedPubMedCentralCrossRef Call J, Walentas CD, Eickhoff JC, Scherzer N. Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry. BMC Cancer. 2012;12:90.PubMedPubMedCentralCrossRef
23.
go back to reference Choi AH, Hamner JB, Merchant SJ, et al. Underreporting of gastrointestinal stromal tumors: is the true incidence being captured? Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2015. Choi AH, Hamner JB, Merchant SJ, et al. Underreporting of gastrointestinal stromal tumors: is the true incidence being captured? Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2015.
24.
go back to reference Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology & Laboratory Medicine. 2006;130(10):1466–1478. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology & Laboratory Medicine. 2006;130(10):1466–1478.
25.
go back to reference Patil DT, Rubin BP. Genetics of gastrointestinal stromal tumors: a heterogeneous family of tumors? Surgical Pathology Clinics. 2015;8(3):515–524.PubMedCrossRef Patil DT, Rubin BP. Genetics of gastrointestinal stromal tumors: a heterogeneous family of tumors? Surgical Pathology Clinics. 2015;8(3):515–524.PubMedCrossRef
26.
go back to reference Rossi S, Gasparotto D, Miceli R, et al. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study. The American Journal of Surgical Pathology. 2015;39(7):922–930.PubMedCrossRef Rossi S, Gasparotto D, Miceli R, et al. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study. The American Journal of Surgical Pathology. 2015;39(7):922–930.PubMedCrossRef
27.
go back to reference Kramer K, Knippschild U, Mayer B, et al. Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST). BMC Cancer. 2015;15:57.PubMedPubMedCentralCrossRef Kramer K, Knippschild U, Mayer B, et al. Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST). BMC Cancer. 2015;15:57.PubMedPubMedCentralCrossRef
Metadata
Title
Population-Based Epidemiology and Mortality of Small Malignant Gastrointestinal Stromal Tumors in the USA
Authors
Taylor M. Coe
Katherine E. Fero
Paul T. Fanta
Robert J. Mallory
Chih-Min Tang
James D. Murphy
Jason K. Sicklick
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 6/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3134-y

Other articles of this Issue 6/2016

Journal of Gastrointestinal Surgery 6/2016 Go to the issue